LGI1 Autoimmune Encephalitis

Immunology

Prevalence

5.0 / 100K

0 drugs in development·0 companies·1 clinical trial

Frequently asked questions

How many clinical trials target LGI1 Autoimmune Encephalitis?

There are 1 clinical trial targeting LGI1 Autoimmune Encephalitis tracked by BioSniper.

What is the prevalence of LGI1 Autoimmune Encephalitis?

The estimated prevalence of LGI1 Autoimmune Encephalitis is approximately 5.0 per 100,000 population.

Deep-dive into LGI1 Autoimmune Encephalitis

Full trial data, competitive analysis, and AI-powered pipeline tracking.

Start Free Analysis
    LGI1 Autoimmune Encephalitis — Drugs in Development & Clinical Trials | BioSniper